Skip to main content

Table 1 Confirmed Virologic Response (CVR) VL<50 at Wk 48 (ITT).

From: Impact of HIV viral diversity and baseline resistance on treatment outcomes and the emergence of resistance: the CASTLE study 48-week results

 

ATV/r n/N (%)

LPV/r n/N (%)

Overall*

343/440 (78)

338/443 (76)

Subtype B

230/291 (79)

210/283 (74)

Subtype Non-B

107/143 (75)

121/148 (82)

AE

23/28 (82)

25/28 (89)

BF

21/27 (78)

31/38 (82)

C

51/73 (70)

52/65 (80)

Other

12/15 (80)

13/17 (76)

  1. * Estimated difference: 1.7 (95% CI, -3.8%, 7.1%). 18 reported HIV subtypes contain 6 subtypes, 3 sub-subtypes and 9 recombinants.